Navigation Links
hERG-CHO K1 Recombinant Cell Line from Upstate

ProductshERG-CHO K1 Recombinant Cell Line from Upstate
Company Upstate
Item hERG-CHO K1 Recombinant Cell Line
Price 
Description PrecisION Ion Channel Cell Lines
High Quality, Functionally-Validated, Ion Channel Cell Lines

Ion channels are well known for having a critical role in nerve and muscle function and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression.

Historically, ion channels have been under exploited as drug targets primarily due to the lack of functional high throughput screening technologies. Over recent years, there has been considerable progress in this important area. However, now there is a requirement for high quality research tools that will allow the full benefit of the new screening technologies to be realised. Upstate has built a portfolio of ion channel cell lines to meet these new and evolving needs in the drug discovery industry.

Our ion channel cell lines are available off of the shelf. These cell lines are fully validated using electrophysiology, stable (>25 passage) and licensed for drug discovery research. The objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology functions.
Info UpstateUpstate
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500 or 951-676-8080
Tech Support: 800 548-7853
Fax Number: 800-437-7502 or 951-676-9209
Web Site: http://www.upstate.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. hERG-CHO K1 Recombinant Cell Line from Upstate
2. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
3. Recombinant RNasin® Ribonuclease Inhibitor from Promega
4. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
5. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
6. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
7. hHCN4-CHO K1 Recombinant Cell Line from Upstate
8. hKv1.5-CHO K1 Recombinant Cell Line from Upstate
9. hNav1.6-HEK293 Recombinant Cell Line from Upstate
10. hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate
11. Smac/DIABLO, Human, Recombinant, E. coli from Calbiochem
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
(Date:1/11/2017)... 2017 Intoxalock, a leading ignition interlock provider, ... its patent-pending calibration device. With this new technology, Intoxalock ... upload data logs and process repairs at service center ... "Fighting drunk driving through the application of cutting-edge technologies ... but also for the customer who can get back ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... , Jan. 24, 2017  Asterias Biotherapeutics, ... the field of regenerative medicine, today announced positive ... 1/2a clinical trial that showed additional motor function ... 10 million AST-OPC1 cells in AIS-A patients with ... "Recovery of upper extremity motor function is critically ...
(Date:1/24/2017)... ... January 24, 2017 , ... Amendia, ... appointment of Steven F. McAllister as Executive Vice President and Chief Financial Officer. ... U.S. and international markets. Beginning his career at Howmedica, Inc., he has since ...
(Date:1/24/2017)... Diego, CA (PRWEB) , ... January 24, 2017 ... ... the development of label-free graphene biosensor assays for fragment-based screening, will ... at the 2017 Society for Laboratory Automation and Screening (SLAS) conference in Washington, ...
(Date:1/24/2017)... ... January 24, 2017 , ... Nor-Tech’s leading-edge demo cluster ... user-friendly bootable Intel KNL. , Currently Cal Tech researchers are testing their ... The demo cluster is a no-cost, no-strings opportunity for current and prospective clients ...
Breaking Biology Technology: